Back to Authors

Chang, A.

A5034482025 | I4210146481

Mayo Clinic

Constellation Pharmaceuticals (United States)

Citations 1

S198: BET INHIBITOR PELABRESIB (CPI-0610) COMBINED WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS — JAK INHIBITOR-NAÏVE OR WITH SUBOPTIMAL RESPONSE TO RUXOLITINIB — PRELIMINARY DATA FROM THE MANIFEST STUDY

HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 99-100

10.1097/01.hs9.0000843684.97625.7e